Adverse event reporting in oncology clinical trials - lost in translation?

Expert Opin Drug Saf. 2016 Jul;15(7):893-6. doi: 10.1080/14740338.2016.1175429. Epub 2016 Apr 27.

Authors

Shanthi Sivendran¹, Matthew D Galsky²

Affiliations

¹ a Penn Medicine at Lancaster General Health , Ann B Barshinger Cancer Institute , Lancaster , PA , USA.
² b Mount Sinai School of Medicine , Tisch Cancer Institute , New York , NY , USA.

PMID: 27070940
DOI: 10.1080/14740338.2016.1175429

No abstract available

Keywords: Adverse event; CONSORT; attribution; harms; patient reported outcomes.

MeSH terms

Adverse Drug Reaction Reporting Systems*
Antineoplastic Agents / adverse effects*
Antineoplastic Agents / therapeutic use
Humans
Neoplasms / drug therapy*
Randomized Controlled Trials as Topic
Research Design

Substances

Antineoplastic Agents